DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis by Henricks, Linda M, PharmD, Lunenburg, Carin A T C, MSc, de Man, Femke M, MD, Meulendijks, Didier, PharmD, Frederix, Geert W J, PhD, Kienhuis, Emma, BSc, Creemers, Geert-Jan, MD, Baars, Arnold, MD, Dezentjé, Vincent O, MD, Imholz, Alexander L T, MD, Jeurissen, Frank J F, MD, Portielje, Johanna E A, Prof, Jansen, Rob L H, MD, Hamberg, Paul, MD, ten Tije, Albert J, MD, Droogendijk, Helga J, MD, Koopman, Miriam, Prof, Nieboer, Peter, MD, van de Poel, Marlène H W, MD, Mandigers, Caroline M P W, MD, Rosing, Hilde, PhD, Beijnen, Jos H, Prof, Werkhoven, Erik van, MSc, van Kuilenburg, André B P, PhD, van Schaik, Ron H N, PhD, Mathijssen, Ron H J, Prof, Swen, Jesse J, PharmD, Gelderblom, Hans, Prof, Cats, Annemieke, MD, Guchelaar, Henk-Jan, Prof, Schellens, Jan H M, Prof

Get full text